This is an index of side effect / adverse reaction reports (a.k.a. adverse event reports) related to Roferon-A (Interferon Alfa-2A) and submitted to the FDA during the sample period of about a year. The information is not vetted and should not be considered as verified clinical evidence.
Reports by Event Outcome
All Cases (77)
Death (16)
Life Threatening Events (8)
Disability (3)
Reports by Reaction Type
Anaemia (9),
Pyrexia (7),
Decreased Appetite (7),
Diarrhoea (6),
Gastrointestinal Perforation (5),
Blood Alkaline Phosphatase Increased (5),
Vomiting (5),
Neoplasm Malignant (5),
Leukopenia (5),
Completed Suicide (4),
Nausea (4),
Neutropenia (4)
Below are a few examples of reports where side effects / adverse reactions may be related to Roferon-A (Interferon Alfa-2A). For a complete list or a specific selection of reports, please use the links above.
Possible Roferon-A side effects in male
Reported by a physician from Serbia on 2012-08-22
Patient: male, weighing 62.0 kg (136.4 pounds)
Reactions: Depression
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Roferon-A
Indication: Renal Cell Carcinoma
Start date: 2009-12-17
End date: 2010-11-03
Avastin
Indication: Renal Cell Carcinoma
Start date: 2009-12-10
End date: 2010-10-27
Other drugs received by patient: Enalapril Maleate; Iron
Possible Roferon-A side effects in female
Reported by a consumer/non-health professional from Brazil on 2012-08-16
Patient: female, weighing 59.0 kg (129.8 pounds)
Reactions: Weight Decreased, Hepatitis C, Nausea, Chills, Hypotension, Pyrexia, Depression, Decreased Appetite
Drug(s) suspected as cause:
Roferon-A
Other drugs received by patient: Miosan; Ribavirin
Possible Roferon-A side effects in 35 year old male
Reported by a physician from Portugal on 2012-08-14
Patient: 35 year old male
Reactions: Asthma, Weight Increased, Cholelithiasis, Biliary Colic, NO Therapeutic Response, Hepatic Steatosis
Drug(s) suspected as cause:
Pegasys
Indication: Hepatitis B
Roferon-A
Indication: Hepatitis B
Other drugs received by patient: Lamivudine; Adefovir
Possible Roferon-A side effects in female
Reported by a physician from Germany on 2012-08-10
Patient: female, weighing 81.0 kg (178.2 pounds)
Reactions: Neoplasm Malignant
Adverse event resulted in: death
Drug(s) suspected as cause:
Roferon-A
Dosage: 3 mio iu
Indication: Renal Cancer
Start date: 2012-05-11
End date: 2012-06-07
Avastin
Indication: Renal Cancer
Start date: 2012-05-10
End date: 2012-06-07
Possible Roferon-A side effects in
Reported by a physician from United States on 2012-08-06
Patient:
Reactions: Weight Decreased, Blood Creatine Phosphokinase Increased, Pyrexia, Cardiac Disorder, Cerebral Haemorrhage, Dyspepsia, DRY Mouth, Blood Creatinine Increased, Blood Alkaline Phosphatase Increased, Stomatitis, Intracranial Tumour Haemorrhage, Anaemia, Aspartate Aminotransferase Increased, Neutropenia, Amylase Increased, Myalgia, Fatigue, Blood Uric Acid Increased, Myocardial Infarction, Thrombocytopenia, Decreased Appetite, Dyspnoea, Vomiting, Nausea, Lymphopenia, Alanine Aminotransferase Increased, Palmar-Plantar Erythrodysaesthesia Syndrome, Rash, Mucosal Inflammation, Hypophosphataemia, Diarrhoea, Respiratory Failure, Arthralgia, Neoplasm Malignant, Ejection Fraction Decreased, Hypothyroidism, Lipase Increased, Hypertension, Asthenia, Leukopenia, Influenza Like Illness
Adverse event resulted in: death
Drug(s) suspected as cause:
Roferon-A
Dosage: given on nonconsecutive days, 3 mu at three times a week during the first week.
Indication: Metastatic Renal Cell Carcinoma
Roferon-A
Dosage: given 6 mu three times a week during second week.
Roferon-A
Dosage: given 9 mu three times a week thereafter.
Possible Roferon-A side effects in male
Reported by a physician from France on 2012-08-01
Patient: male
Reactions: Blood Alkaline Phosphatase Increased, Hyperkalaemia, Anaemia, Lymphopenia, Bacterial Pyelonephritis, Hyponatraemia, Klebsiella Infection, Renal Failure, Gamma-Glutamyltransferase Increased, Cardiac Failure, Posterior Reversible Encephalopathy Syndrome, Pulmonary Oedema
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Avastin
Indication: Renal Cancer
Start date: 2011-11-08
End date: 2011-11-08
Roferon-A
Indication: Renal Cancer
Start date: 2011-10-24
End date: 2011-11-21
Other drugs received by patient: Allopurinol; Candesartan Cilexetil; Previscan (France); Proscar; Temerit
Possible Roferon-A side effects in male
Reported by a physician from United States on 2012-07-27
Patient: male, weighing 93.0 kg (204.6 pounds)
Reactions: Cerebral Infarction
Drug(s) suspected as cause:
Avastin
Dosage: permanently discontinued on 23 feb 2009.
Roferon-A
Roferon-A
Dosage: withheld on 17/feb/2009
Indication: Renal Cell Carcinoma
Avastin
Dosage: withheld on 17 feb 2009
Indication: Renal Cell Carcinoma
Start date: 2008-12-09
End date: 2009-02-23
Other drugs received by patient: Phospho-Soda; Ferrous Sulfate TAB; Lisinopril; Maalox TC; Glipizide; Omega-3 Triglycerides; Vicodin; Simvastatin
Possible Roferon-A side effects in 66 year old male
Reported by a physician from Germany on 2012-07-20
Patient: 66 year old male
Reactions: Proteinuria, Neutropenia, Pyrexia, Hypertension, Thrombocytopenia, Leukopenia
Drug(s) suspected as cause:
Roferon-A
Indication: Product Used FOR Unknown Indication
Avastin
Indication: Renal Cell Carcinoma
Possible Roferon-A side effects in male
Reported by a physician from Belgium on 2012-07-18
Patient: male, weighing 92.0 kg (202.4 pounds)
Reactions: Pancreatitis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Avastin
Dosage: last dose prior to adverse event 17 aug 2012
Indication: Renal Cell Carcinoma
Start date: 2010-03-30
End date: 2010-08-30
Avastin
Dosage: cyclic
Start date: 2010-09-28
Roferon-A
Dosage: dose: 97, form: not provided.
Indication: Renal Cell Carcinoma
Other drugs received by patient: Tramadol HCL; Nexium; Colchicine; Lipitor; Feldene; Exforge
Possible Roferon-A side effects in male
Reported by a physician from Germany on 2012-07-18
Patient: male, weighing 106.8 kg (235.0 pounds)
Reactions: Blood Alkaline Phosphatase Increased, Pneumonia, Anaemia, Pneumonitis
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Roferon-A
Possible Roferon-A side effects in male
Reported by a physician from Germany on 2012-07-11
Patient: male, weighing 62.2 kg (136.8 pounds)
Reactions: Blood Alkaline Phosphatase Increased, Hyperbilirubinaemia, Anaemia, Transaminases Increased
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Roferon-A
Possible Roferon-A side effects in male
Reported by a physician from Hungary on 2012-07-09
Patient: male, weighing 57.0 kg (125.4 pounds)
Reactions: Haemoglobin Decreased, Cardiopulmonary Failure, Asthenia, Decreased Appetite
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Roferon-A
Dosage: reported as roferon.dose: 3 mu. frequency weekly 3
Indication: Renal Cell Carcinoma
Start date: 2008-09-25
End date: 2008-10-08
Avastin
Dosage: frequency reported as bi weekly
Indication: Renal Cell Carcinoma
Start date: 2008-09-25
End date: 2008-10-08
Other drugs received by patient: Ensure
Possible Roferon-A side effects in male
Reported by a physician from India on 2012-06-28
Patient: male, weighing 71.0 kg (156.2 pounds)
Reactions: Haemoptysis, Lower Respiratory Tract Infection
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Roferon-A
Dosage: dose: 9 million iu
Indication: Metastatic Renal Cell Carcinoma
Avastin
Indication: Metastatic Renal Cell Carcinoma
Start date: 2010-09-10
End date: 2011-04-07
Other drugs received by patient: Amlodipine
Possible Roferon-A side effects in female
Reported by a consumer/non-health professional from Russian Federation on 2012-06-27
Patient: female
Reactions: Tongue DRY, Monocyte Count Increased, Haemoglobin Decreased, Haematocrit Decreased, RED Blood Cell Count Decreased, Neutrophil Count Decreased, Leukopenia, RED Blood Cell Sedimentation Rate Increased
Drug(s) suspected as cause:
Roferon-A
Indication: Hepatitis C
Ribavirin
Administration route: Oral
Indication: Hepatitis C
Interferon Alfa-2B
Indication: Hepatitis C
Possible Roferon-A side effects in 65 year old male
Reported by a health professional (non-physician/pharmacist) from France on 2012-06-22
Patient: 65 year old male, weighing 58.0 kg (127.6 pounds)
Reactions: Vomiting, Psychomotor Retardation, Flatulence, General Physical Health Deterioration, Blood Chloride Increased, Disorientation, Hypernatraemia, Haemoconcentration, Hypercalcaemia, Cachexia, Dehydration, Protein Total Increased, Haemoglobin Increased, Renal Failure Acute
Adverse event resulted in: death
Drug(s) suspected as cause:
Targretin
Indication: Mycosis Fungoides
Start date: 2009-11-01
End date: 2011-12-05
Emend
Administration route: Oral
Indication: Vomiting
Start date: 2011-09-01
Roferon-A
Dosage: miu
Indication: Mycosis Fungoides
Start date: 2010-11-01
Other drugs received by patient: Nutritional Supplements; Levothyroxine Sodium; Xerial 50; Amitriptyline Hydrochloride; Lexomil
Possible Roferon-A side effects in male
Reported by a individual with unspecified qualification from France on 2012-06-20
Patient: male, weighing 75.0 kg (165.0 pounds)
Reactions: Confusional State, Hypoglycaemia, Amnesia, Decreased Appetite
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Roferon-A
Indication: Metastatic Renal Cell Carcinoma
Start date: 2009-03-31
End date: 2010-01-21
Avastin
Indication: Metastatic Renal Cell Carcinoma
Start date: 2009-03-31
End date: 2010-01-18
Other drugs received by patient: Omix; Ginkogink; Imodium; Acetaminophen; Aspirin; Omeprazole; Vitamin D; Lexomil; Glucophage; Dipyridamole; Ezetimibe; Motilium-M
Possible Roferon-A side effects in female
Reported by a physician from Korea, Republic of on 2012-06-18
Patient: female, weighing 50.3 kg (110.7 pounds)
Reactions: Myalgia, Fatigue, Ventricular Tachycardia, Cardiac Arrest, Decreased Appetite
Adverse event resulted in: death
Drug(s) suspected as cause:
Avastin
Indication: Renal Cell Carcinoma
Start date: 2010-02-23
End date: 2010-11-05
Roferon-A
Indication: Renal Cell Carcinoma
Start date: 2010-02-23
End date: 2010-11-05
Possible Roferon-A side effects in male
Reported by a physician from Korea, Republic of on 2012-06-18
Patient: male
Reactions: Haemoptysis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Avastin
Indication: Metastatic Renal Cell Carcinoma
Start date: 2009-09-21
End date: 2010-05-31
Roferon-A
Indication: Metastatic Renal Cell Carcinoma
Start date: 2009-09-21
End date: 2010-05-31
Possible Roferon-A side effects in female
Reported by a physician from Hong Kong on 2012-06-15
Patient: female, weighing 73.3 kg (161.3 pounds)
Reactions: Drug Ineffective, Anaemia, Metastases To Bone, Disease Progression
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Avastin
Indication: Metastatic Renal Cell Carcinoma
Start date: 2009-05-20
End date: 2010-04-05
Roferon-A
Start date: 2010-05-03
End date: 2010-05-14
Roferon-A
Indication: Metastatic Renal Cell Carcinoma
Start date: 2009-05-20
End date: 2010-04-05
Avastin
Start date: 2010-05-03
End date: 2010-05-14
Possible Roferon-A side effects in male
Reported by a physician from Hong Kong on 2012-06-14
Patient: male, weighing 69.7 kg (153.3 pounds)
Reactions: Abdominal Pain, Renal Cell Carcinoma Recurrent, Vomiting, Intra-Abdominal Haematoma, Anaemia, Neoplasm Progression, Pyrexia, Diarrhoea
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Avastin
Start date: 2009-09-09
Roferon-A
Indication: Renal Cell Carcinoma
Start date: 2009-06-17
End date: 2009-06-19
Roferon-A
Start date: 2009-09-09
Avastin
Indication: Renal Cell Carcinoma
Start date: 2009-06-17
End date: 2009-06-17
Roferon-A
Start date: 2009-06-29
End date: 2009-08-12
Avastin
Start date: 2009-11-25
Other drugs received by patient: Pepcidine; Acetaminophen; Piperacillin; Diclogesic Relax
Possible Roferon-A side effects in male
Reported by a physician from France on 2012-06-14
Patient: male, weighing 90.0 kg (198.0 pounds)
Reactions: Cholelithiasis, Neoplasm Malignant, Pulmonary Embolism
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Avastin
Indication: Renal Cell Carcinoma
Start date: 2009-04-27
End date: 2009-07-08
Roferon-A
Indication: Renal Cell Carcinoma
Start date: 2009-04-27
End date: 2009-06-29
Possible Roferon-A side effects in male
Reported by a physician from Germany on 2012-06-14
Patient: male, weighing 82.0 kg (180.4 pounds)
Reactions: Weight Decreased, Drug Ineffective, Neoplasm Malignant, Anaemia, General Physical Health Deterioration, Anaemia of Malignant Disease, Decreased Appetite
Adverse event resulted in: life threatening event, hospitalization, disablity
Drug(s) suspected as cause:
Avastin
Start date: 2010-10-11
Roferon-A
Start date: 2010-09-27
Avastin
Start date: 2011-01-30
Roferon-A
Start date: 2010-10-11
Avastin
Indication: Metastatic Renal Cell Carcinoma
Start date: 2010-08-02
End date: 2010-09-27
Roferon-A
Indication: Metastatic Renal Cell Carcinoma
Start date: 2010-08-02
End date: 2010-09-27
Possible Roferon-A side effects in male
Reported by a physician from Spain on 2012-06-14
Patient: male, weighing 78.0 kg (171.6 pounds)
Reactions: Vomiting, Diarrhoea, Toxicity To Various Agents, Pyrexia, Asthenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Roferon-A
Indication: Metastatic Renal Cell Carcinoma
Start date: 2010-01-11
End date: 2010-03-12
Avastin
Administration route: Oral
Indication: Metastatic Renal Cell Carcinoma
Start date: 2010-01-11
End date: 2010-01-19
Other drugs received by patient: Omeprazole; Tramadol HCL; Nolotil
Possible Roferon-A side effects in male
Reported by a physician from Belgium on 2012-06-14
Patient: male, weighing 80.0 kg (176.0 pounds)
Reactions: Toxicity To Various Agents
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Avastin
Indication: Metastatic Renal Cell Carcinoma
Start date: 2009-09-24
End date: 2010-03-26
Avastin
End date: 2010-04-12
Roferon-A
Dosage: 6 mui, last dose on 24/may/2010
Indication: Metastatic Renal Cell Carcinoma
Start date: 2009-09-24
End date: 2010-05-24
Other drugs received by patient: Cardizem; Motilium (Belgium); Escitalopram Oxalate; Acetaminophen; Zovirax; Omeprazole
Possible Roferon-A side effects in male
Reported by a health professional (non-physician/pharmacist) from France on 2012-06-14
Patient: male, weighing 57.0 kg (125.4 pounds)
Reactions: Intestinal Obstruction
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Roferon-A
Dosage: 9 miu, qd, last dose on 11-sep-2009
Indication: Renal Cell Carcinoma
Start date: 2009-03-25
End date: 2009-09-11
Avastin
Dosage: last dose on 11-sep-2009
Indication: Renal Cell Carcinoma
Start date: 2009-03-25
End date: 2009-09-11
Possible Roferon-A side effects in female
Reported by a physician from France on 2012-06-14
Patient: female, weighing 58.0 kg (127.6 pounds)
Reactions: Atelectasis, Posterior Reversible Encephalopathy Syndrome
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Avastin
Indication: Metastatic Renal Cell Carcinoma
Start date: 2009-07-17
End date: 2010-11-09
Roferon-A
Indication: Metastatic Renal Cell Carcinoma
Start date: 2009-10-23
End date: 2010-11-09
Other drugs received by patient: Keppra; Neurontin; Irbesartan; Morphine Sulfate; Forlax (France); Effexor; Acetaminophen; Duragesic-100; Lovenox
Possible Roferon-A side effects in male
Reported by a physician from France on 2012-06-14
Patient: male, weighing 74.0 kg (162.8 pounds)
Reactions: Cerumen Impaction, Vertigo, Haematoma
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Roferon-A
Indication: Metastatic Renal Cell Carcinoma
Start date: 2010-06-24
End date: 2010-08-18
Avastin
Indication: Metastatic Renal Cell Carcinoma
Start date: 2010-06-24
End date: 2010-08-05
Avastin
Start date: 2010-09-09
End date: 2010-09-16
Roferon-A
End date: 2010-09-16
Other drugs received by patient: Lovenox
Possible Roferon-A side effects in male
Reported by a individual with unspecified qualification from France on 2012-06-13
Patient: male, weighing 94.0 kg (206.8 pounds)
Reactions: Pyelonephritis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Roferon-A
Start date: 2010-01-21
Avastin
Start date: 2010-01-21
Avastin
Indication: Renal Cell Carcinoma
Start date: 2009-03-31
End date: 2009-08-03
Roferon-A
Indication: Renal Cell Carcinoma
Start date: 2009-03-31
End date: 2009-08-07
Possible Roferon-A side effects in male
Reported by a physician from United Kingdom on 2012-06-13
Patient: male, weighing 74.8 kg (164.6 pounds)
Reactions: Tinnitus, Deafness
Drug(s) suspected as cause:
Avastin
Indication: Metastatic Renal Cell Carcinoma
Start date: 2009-09-03
Roferon-A
Dosage: 3 miu
Indication: Metastatic Renal Cell Carcinoma
Start date: 2009-09-03
Possible Roferon-A side effects in male
Reported by a physician from Belgium on 2012-06-13
Patient: male, weighing 75.0 kg (165.0 pounds)
Reactions: Vascular Pseudoaneurysm, Hypertension
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Roferon-A
Dosage: daily dose: 3 10e6 iu
Start date: 2011-01-19
End date: 2011-02-13
Roferon-A
Dosage: daily dose: 9 10e6 iu
Indication: Metastatic Renal Cell Carcinoma
Start date: 2010-09-01
End date: 2010-11-10
Avastin
Indication: Metastatic Renal Cell Carcinoma
Start date: 2010-09-01
End date: 2011-02-16
Roferon-A
Dosage: daily dose: 6 10e6 iu
Start date: 2010-11-14
End date: 2011-01-06
Other drugs received by patient: Tritace; Valsartan
|